Repligen (RGEN) Operating Expenses (2010 - 2026)

Repligen (RGEN) has reported Operating Expenses for 17 consecutive years, with $190.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses rose 12.87% year-over-year to $190.2 million in Q2 2026; TTM through Jun 2026 was $720.5 million, a 3.25% increase from a year earlier, with the FY2025 full-year figure at $683.1 million, up 2.02% from the prior year.
• Operating Expenses was $190.2 million for Q2 2026 at Repligen, up from $178.3 million in the prior quarter.
• Over five years, Operating Expenses peaked at $204.0 million in Q4 2024 and troughed at $136.5 million in Q3 2023.
• A 5-year average of $160.1 million and a median of $155.1 million in 2023 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses jumped 37.52% in 2022 and slipped 11.76% in 2025, its largest moves.
• Over 5 years, Operating Expenses stood at $137.9 million in 2022, then increased by 13.65% to $156.7 million in 2023, then jumped by 30.18% to $204.0 million in 2024, then slipped by 11.76% to $180.0 million in 2025, then gained by 5.61% to $190.2 million in 2026.
• The last three Operating Expenses figures came in at $190.2 million (Q2 2026), $178.3 million (Q1 2026), and $180.0 million (Q4 2025), per Business Quant data.